《中国寄生虫学与寄生虫病杂志》创刊于1983年。40年来，该刊见证了我国重要寄生虫病防治取得的巨大成就，尤其是有效控制了血吸虫病（2015）、消除了淋巴丝虫病（2007年）和疟疾（2021），为寄生虫病防治研究提供了重要的学术交流平台，促进了国内外学术交流。在历届编委会的悉心指导下，该刊严守学术标准，坚守精品办刊理念，国内国际影响力不断提升。创刊不久，先后被国内外重要数据库收录，国际被Medline、Scopus收录，国内被“中国科技引文数据库（CSCD，C库）”等收录，分别入选“中国科技核心期刊”“中文核心期刊”“科技期刊世界影响力指数（WJCI）报告”“预防医学与卫生学高质量科技期刊分级目录”。曾被评选为“百种中国杰出学术期刊”“卫生部首届医药卫生优秀期刊一等奖”“国家卫生计生委首届优秀期刊奖”“中华预防医学系列杂志优秀期刊一等奖/优秀奖”和“华东地区优秀期刊奖”等。2021年的核心影响因子为1.743，再创历史新高，继续在31本基础医学类核心期刊中位列首位。2006年启动网络信息化建设，2016年建立了“微信”平台，使期刊的传播、服务能力和影响力显著提升。本文总结了《中国寄生虫学与寄生虫病杂志》创刊40年来的办刊历程，并对未来发展提出愿景。

The Chinese Journal of Parasitology and Parasitic Diseases had its first issue in 1983. Over the past 40 years, the journal witnesses the remarkable achievements in prevention and control of important parasitic diseases in China, marked by effective control of schistosomiasis (2015) and elimination of lymphatic filariasis (2007) and malaria (2021), and has been playing an important role providing academic exchange platform for research and control programs of parasitic diseases and parasitology, promoting domestic and international scientific exchanges. With the guidance of each editorial board, the journal strictly abides by the academic standards and perseveres the concept of presenting high-quality publication. The national and international impact of the journal has continuously increased. It has been included in important international databases such as Medline, Scopus, and Chinese Science Citation Database (CSCD) (Class C) since 1989. It has been selected as one of Chinese Science and Technology Core Journals since 1987, Core Journals in Chinese since 1992 and the World Journal Clout Index Report Scientific & Technological Periodicals (WJCI) since 2020, and was included in the High-Quality Scientific and Technological Journal Classification Catalog for Preventive Medicine and Health (2021 edition). It was also awarded as one of “the 100 Outstanding Chinese Academic Journals” (in 2009), “the First Prize of Excellent Medical and Health Journals of the Ministry of Health” (in 2005), “the First Prize of Excellent Journals of the National Health and Family Planning Commission” (in 2013), the First Prize and the Excellent Journal of “the Journal series of the Chinese Preventive Medicine Association” and “the Excellent Journal Award in East China Region”. In 2021, its core impact factor reached 1.743, the highest in its history, and continues its first rank among 31 core journals in medicine. The network informatization has been constructed since 2006, with "WeChat" platform established in 2016, which has raised the journal’s dissemination, service capacity and impact to a higher level. This article summarizes the 40-year history of the Chinese Journal of Parasitology and Parasitic Diseases, and prospects its future development direction.